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Ensuring Dermatology’s Future
the founders of the Society for Investigative Dermatology (SID) envisioned that a sci-entific society and journal devoted to skin 
research would be essential elements for future 
progress. Now, after 75 successful years, this 
generation must determine what elements are 
necessary for the continued expansion of knowl-
edge about skin and its diseases. Our founders 
were no doubt influenced by one of the sci-
entific superstars, Paul Ehrlich, 1908 Nobel 
Laureate, developer of the idea of rational che-
motherapy, and discoverer of Salvarsan (606), 
the first effective treatment for syphilis. Ehrlich 
summed up the requirements for success in 
research with the four G’s: Glück (luck), Geduld 
(patience), Geschick (skill), and Geld (money) 
(Ehrlich, 1913). These characteristics are equal-
ly important today, as evidenced in many of 
the articles in this issue. There has been steady 
growth in the impact factor and hence the sci-
entific importance of the Journal of Investigative 
Dermatology, a measure of Geduld among 
many of its editors over decades (Bickers and 
Modlin, 2012). This issue of JID allows further 
consideration of the elements of success and 
establishes directions for what dermatological 
scientists should consider doing today to ensure 
progress in the future. The six Is (integration, 
internationalism, innovation, industrial interac-
tions, improving health, and implementation) 
are outlined in proposing a plan for immediate 
implementation. When our founders decided 
on a society and a journal, it was not for some 
future date but immediately. There is similar 
urgency for instituting our current plans.
If a single word is essential for our vision of 
progress, that word is INTEGRATION.
integration: internal environments
Physiology, the function of the skin, has always 
been a significant part of investigative derma-
tology, as reflected in the first five chapter titles 
of Stephen Rothman’s classic text, Physiology 
and Biochemistry of the Skin. They include 
mechanical properties, electrical behavior, per-
cutaneous absorption, circulation and vascular 
reactions, sensory function, and sweat secretion 
(Rothman, 1955). Today, physiology may heuris-
tically be considered under the twin rubrics of 
systems biology and -omics. The “ome” is used to 
signify a set of related functions, their character-
ization, and, especially, their interrelationships. 
“Omics” began as genomics but was rapidly co-
opted as a suffix to form other omics. The identi-
ties of current omes and omics are obvious from 
their names and include genomics, transcrip-
tomics (DiGiovanna and Kraemer, 2012), pro-
teomics (Coulombe and Lee, 2012; Brown and 
McLean, 2012; Capon et al., 2012; Amagai and 
Stanley, 2012), metabolomics (Rees and Harding, 
2012), pharmacogenomics, physiomics 
(Mascia et al., 2012; Yaar and Park, 2012; Betz 
et al., 2012; Capon et al., 2012), cellular inter-
actome (Ghadially, 2012), microbiome (Kong 
and Segre, 2012; Nakatsuji and Gallo, 2012), 
diseasomics (Kupper, 2012; Loser and Beissert, 
2012; Nikolau et al., 2012), skinomics (Cheng 
and Cho, 2012; Blumenberg, 2005), and expo-
somics (Ryan, 2012; Gutowska-Owsiak and Ogg, 
2012; DeLouise, 2012; Krutmann et al., 2012; De 
Benedetto et al., 2012; Ullrich and Byrne, 2012; 
Romani et al., 2012; Nakatsuji and Gallo, 2012; 
Modlin, 2012; DeLouise, 2012). Omic studies, 
which are found throughout this issue, often con-
centrate on signaling interactions (Mascia et al., 
2012; Yaar and Park, 2012).
Systems biology is a greatly expanded concep-
tion of physiology at the intersection of biology, 
mathematics, engineering, and the physical sci-
ences. It encompasses multiple levels of the 
biological information hierarchy in spatial, tem-
poral, environmental, and evolutionary contexts 
(paraphrased from http://www.nigms.nih.gov/
Research/FeaturedPrograms/SysBio).
Understanding the function and the dys-
function of cutaneous biological systems will 
require knowledge of multiple molecules, both 
temporally and spatially, and it is not surpris-
ing that imaging will be a major tool in all 
biological studies, especially in studies of the 
skin (http://www.keckfutures.org/conferences/
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effort will be required to characterize exposures accurately, 
as is now being done with internal cellular constituents. 
These efforts are beginning, as are analytical and interpre-
tative techniques for quantitating the interaction between 
the genome and environmental variables (Dempfle et al., 
2008; Bookman et al., 2011).
Microbiological agents that are commensural or patho-
logical for skin have also been studied extensively. With 
“microbiome” studies of skin and other tissues, many 
new organisms have been identified, as have their roles 
in health and disease (Kong and Segre, 2012). Such stud-
ies address quantitative interactions among many species 
of organisms, various cutaneous structural molecules in 
and on cells, and the innate and acquired immune systems 
(Nakatsuji and Gallo, 2012; Brown and McLean, 2012; 
Modlin, 2012; Romani et al., 2012).
Recommendation: The complexity of interactions 
between the internal and external environments requires 
new and sophisticated techniques of data analysis. Having 
trainees focus on measuring environmental influences 
should be an important priority in skin research. Trainees 
must develop expertise in mathematical tools of analy-
sis and experimental design, leading to complex studies 
of gene–environment interaction, and they must learn by 
being part of large interdisciplinary teams of investigators.
internationalism
Scientific endeavors are now international in nature (Uitto 
and Rodeck, 2012). Scientists have frequently traveled to 
learn from a master at a distant site; such relationships can 
become even more productive when they involve exchanges 
between geographic locations, providing greater chances 
of success. Many of the articles in this special issue demon-
strate the importance of training, mentoring, and access to 
special populations of patients (Brown and McLean, 2012). 
Since its first issue, JID has had an international focus, and 
the SID and ESDR have significant international representa-
tion and interactions. Investigative societies such as the SID, 
the ESDR, the Japanese Society of Investigative Dermatology 
(JSID) and other emerging scientific organizations through-
out the world should have more combined meetings. The 
current International Investigative Dermatology (IID) meet-
ing represents one such example. The commitment of 
the SID, the ESDR and the JSID to forego their respective 
annual meetings in order to support a combined IID meet-
ing at five-year intervals shows very high commitments by 
the organizations and attests to the values of such multi-
national gatherings. Although such meetings are sometimes 
constrained by costs, complex scheduling, and logistical 
issues, they allow face-to-face interaction, accelerating the 
pace of international collaboration.
Recommendation: More international interaction using 
telecommunications, video, webinars, and virtual poster 
sessions will accelerate the pace of scientific interactions. 
Dermatological science should be at the forefront of such 
activities, and the relatively small size of the entire skin 
biology community is an additional cogent reason for such 
international efforts.
imaging-science.html). Combining molecular studies and 
morphological studies is essential to stem cell studies in 
skin and its appendages (Ghadially, 2012).
Understanding the consequences of altered physiology 
is critical for the treatment of genetic diseases (Betz et al., 
2012; Uitto et al., 2012). Restoring altered genes to normal 
is just one way of altering the effect of genetic diseases; 
there may be more effective, safer, and even less costly 
ways of correcting the altered physiology of genetic disease 
(Capon et al., 2012). Studies of pseudoxanthoma elasticum 
are a good example of how a disordered hepatic trans-
porter may be treatable by altering the mineral balance in 
a patient (Uitto et al., 2011). Systems approaches should 
allow scientists to consider all of the potential ways of 
treating or preventing disease.
The immune system, a major focus of investigative stud-
ies, is a prototypic, complex interacting system that ben-
efits from multidimensional analysis (Loser and Beissert, 
2012; Kupper, 2012).
Recommendation: Skin biologists should explore 
intensively the systems biological approaches to skin. The 
integration of biochemical and morphological studies has 
been a signature of skin research for more than a century. 
Using new tools, skin researchers should be leaders in sys-
tems biology. Attending meetings and presentations that 
emphasize systems biology should be imperative for senior 
investigators and their fellows, and meetings of the SID and 
the European Society for Dermatological Research (ESDR) 
can be forums for such interactions, as can special articles 
in JID and presentations at the Montagna Symposia on 
Biology of the Skin.
integration: external environment
In addition to the internal characteristics of biological sys-
tems relevant for both normal physiology and disease, all 
organs are subject to major and minor external perturbing 
influences. External agents—the “exposome”—include 
microorganisms and chemical and physical influences, and 
they may affect the biosphere even before the time of an 
individual’s conception as well as throughout life (Wild, 
2005; Rappaport, 2011). These events may leave specific 
fingerprints (biomarkers), but evidence of exposure per se is 
often based on potentially biased or inaccurate techniques 
such as surveys, memory, and administrative records. 
Skin biologists have had long-term interest and expertise 
in the effects of environmental influences, including spe-
cific wavelengths in the electromagnetic spectrum, chemi-
cals such as carcinogens, antigens that involve allergic or 
irritation reactions, and nanoparticles (DeLouise, 2012). 
Identification of biomarkers will reveal the effects of such 
agents (Birch-Machin and Swalwell, 2010; Krutmann et al., 
2012; Ullrich and Byrne, 2012; DeLouise, 2012). Systems 
approaches in dermatologic sciences allow the integration 
of studies of stratum corneum integrity with stimulation of 
the immune system (De Benedetto et al., 2012).
Because these environmental effects can affect the 
nuclear and mitochondrial genomes (both genetically and 
epigenetically) and other cellular constituents, significant 
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innovation
Over the next few decades, biological and medical 
sciences will no doubt develop further into “big” science, 
with specialized centers related to analytical expertise or 
technology. Central, international, planned experimental 
facilities—the norm in high-energy physics—will increas-
ingly be the model for the biological and medical sciences.
Increased central planning, nationally and internation-
ally, will occur, and the number of investigators who pur-
sue modestly scaled research will be even smaller than it is 
today. The National Institutes of Health (NIH), the National 
Science Foundation (NSF), the Wellcome Trust, the Max 
Planck Institutes, the National Academies of Sciences, 
Howard Hughes Medical Research Institutes, and some 
private foundations that are more disease focused will 
remain major players in planning and in the allocation of 
funding.
One of the challenges of big science is the development 
of truly novel concepts. Ideas come from many sources: 
the solitary individual, the observation of a patient, read-
ing in one’s own field, reading in another field and making 
associations, and interaction with students, scientists, and 
clinicians, in addition to the careful consideration of labo-
ratory results that do not make sense. Inspiration can come 
from the wonders of nature or of another human being 
and discerning how that person envisions and studies 
his or her science. Interaction with an inspiring individ-
ual can be an important motivating activity for a lifetime. 
Innovation must be rewarded, making consideration of the 
article by Pentland et al. (2012) on patenting very useful.
Recommendation: Institutions must recognize the 
collaborative nature of many of the newer fields of inves-
tigation and should develop ways of recognizing the 
contributions of individual investigators within com-
plex team efforts. Support and mentoring systems will be 
even more important in the future than they are today, 
because the nature of the scientific enterprise will change 
(de Guzman Strong and Cornelius, 2012).
Our two societies should enhance our scientists’ expo-
sure to inspirational individuals. Inspiration develops a 
community. The societies should develop inspirational 
events and inspirational interactions at their real and vir-
tual meetings. The “collegiality program” started by the 
ESDR and individual traveling fellowships should be 
expanded.
industrial interactions
Significant biomedical research related to the skin and 
skin diseases is occurring in industry around the world. 
The reward system and economic models in industry may 
differ from those of academia and national laboratories, 
but the involvement by industry has potential strengths for 
both basic and translational research.
Recommendation: Regularly scheduled industrial and 
academic forums should be fostered by academic societies 
to develop long-range agendas, to eliminate barriers to 
effective interactions with industry, and to explore and 
extend proven models. The articles by Parrish (2012) and 
Bauer and Cohen (2012) in this special issue are a use-
ful starting point for such discussions because industry is 
evolving no less than academia. Productive relationships 
will depend on meeting joint needs.
improving health
Improving human health as it relates to the skin and 
its diseases remains an essential feature of the contract 
between scientists and physicians and society. Fulfilling 
this contract promotes continued funding of our investiga-
tions. Health research encompasses efforts focused on both 
individuals and populations. Populations have differences 
in their inherent genetic components, and their nutrition 
and environmental exposures may be quite different (Capon 
et al., 2012; Nijsten and Stern, 2012; Rees and Harding, 
2012). Methods of analysis should account for these 
increased levels of complexity.
The results from population studies may not be intuitively 
obvious to the general public, and they are often the source of 
considerable controversy between the public at large and the 
scientists who study interventions to improve health (Chren, 
2012). Often, the results of many individual studies must be 
combined to determine whether interventions are effective.
The morphological diagnosis of disease developed over 
two centuries by our clinical forebears is only a gross tech-
nique. Redefinition of diseases may be necessary as we 
interpret population-based data from large-scale genetic 
screening studies. Redefinition is most important as sub-
sets of patients with different responses to intervention are 
identified. The collection and analysis of population-based 
and clinical trial data are as difficult as well-controlled 
laboratory experiments, and those challenges and appro-
priate approaches to handling such data are outlined in this 
issue and elsewhere (Nijsten and Stern, 2012; Williams and 
Dellavalle, 2012).
Measures for progress will be important for determin-
ing whether efforts to improve health and understanding are 
working, validated, and published (Williams and Dellavalle, 
2012). Determining how the environment can be altered to 
improve health will extend traditional skin researchers beyond 
their “comfort zones” because they must enter politics and 
influence national and international funding and research pri-
orities by becoming active advocates for science and health 
(Bergstresser et al., 2012).
There are numerous nonscientific shapers of the biomedi-
cal research universe. The worldwide political pressures 
brought by budgeting constraints and dividing health and sci-
ence budgets among universities, industries, and the public 
should not be underestimated. To ensure proper funding, edu-
cation of the public at large, as well as of members of legisla-
tive bodies, is a high priority, and it will require a carefully 
crafted message about the benefits of the sciences—without 
promising what cannot be delivered.
Recommendation: Scientists must present their needs and 
rationales more effectively than they do today.
For the dermatologic sciences to improve the health of 
the population, health concepts should be part of the train-
ing of all skin researchers; these individuals must gain skills in 
editorial
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advocacy in order to influence the opinion makers in society: 
patient advocate groups, politicians, the press, and the gen-
eral public. Being an effective advocate is intrinsic to being 
a mature scientist; our professional societies must present a 
visible model for advancing these goals.
implementation
The SID, the ESDR, the JSID, and other emerging skin 
research societies will be strongly encouraged to begin open 
blogs and open discussion groups online to facilitate con-
tinued, vibrant discussions. We will capture the best ideas, 
debate them, and create our agenda for the next 75 years.
This Editorial is a modest beginning, but a necessary 
one, as we move toward the SID centennial and recommit 
ourselves to fulfill our own vision and that of our founders.
Lowell A. Goldsmith
Editor Emeritus
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